Pharmaceutical company Cosette Pharmaceuticals Inc revealed on Monday that it has acquired G&W Laboratories' finished dosage manufacturing plant located in Lincolnton, NC, expanding Cosette's capabilities into new dosage forms.
Financial details of the acquisition were not disclosed.
Walt Kaczmarek, president and chief executive officer of Cosette, said: "The Lincolnton facility has an excellent track record of producing liquid pharmaceuticals along with other differentiated dosage forms, and operates as a contract manufacturer across multiple presentations for select business partners. We look forward to integrating their expertise and capabilities to the Cosette family and adding value to the Cosette growth pathway."
Cosette Pharmaceuticals specializes in the areas of dermatology and allergy, with products available in dosage forms such as creams, ointments, lotions, solutions, gels, pastes and suppositories.
NICE recommends ALK's ACARIZAX for house dust mite allergic rhinitis treatment in UK's NHS
European Commission approves Palforzia for toddlers with peanut allergy
Eli Lilly and Co receives approval from FDA for Zepbound
CSL gains EMA backing for Garadacimab as HAE prophylactic treatment
Allergy Therapeutics reports positive data from VLP Peanut PROTECT trial
CBC Group acquires UCB's mature neurology and allergy business in China
Allergy Therapeutics begins Phase III trial for grass allergy treatment in children